Accelerating Glycomics Market During COVID-19 Outbreak
The increasing number of patients suffering from chronic diseases is anticipated to revive the growth of the global glycomics market. The market is expected to witness abundance of growth opportunities in the upcoming years. The increasing presence of pharmaceutical companies and research institutes to boost the drug discovery and development sector is driving the global glycomics market. Advancements in this field have played a major role in drug investigation during coronavirus pandemic. Technological advancements on biotechnology, investments on R&D activities to study gycans or polysaccharides, and increasing applications in disease diagnostics are creating revenue opportunities amid pandemic in the global market.
Request a sample to get extensive insights into the Glycomics Market
Surging Demand for Pharmaceutical Drugs and Treatments Globally
The global glycomics market is projected to cross US$ 3.1 Bn by 2031. The increasing demand for treatments for various chronic diseases is fueling the growth of the global glycomics market. Pharmaceutical companies are paving their ways in the global market to support R&D activities in glycans to generate more revenue opportunities. Increasing government expenditure on healthcare as well as in research & development activities in bioinformatics strengthen the scope and expansion of the market. Since cancer is one of the leading causes of death, there is an increasing focus of market contributors to support drug discovery and development activities in the field of oncology to create profitable opportunities.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Government Initiatives to Support and Invest in R&D Activities
Glycomics is the study of structure, biology, and function of saccharides or glycans, which can be found in all living organisms. The application of glycobiology in drug discovery & development, disease diagnostics, oncology, immunology, etc. has created tremendous growth opportunities for the players operating in the global market. The global glycomics market is expected to expand at a CAGR of 11.2% during the forecast period of 2021-2031. Pharmaceutical companies are increasing their output capacities to support the global glycomics market. Governments are taking steps ahead to support manufacturers in the pharmaceutical companies, and investing in R&D activities. The increasing healthcare expenditure by governments of developing countries to support research activities in the global market help fuel market growth.
Expansion of Academic & Research Institutes to Support Market Growth
Growth and advancement academic & research institutes to study glycomics, which has many applications in rapid development of drugs, vaccine development, and precision medicines, are factors expected to drive the global market during the forecast period. Increasing collaborations between research institutions and key market contributors to support research activities in biomedical and biochemistry are responsible for generating revenue streams. Expanding contact research organizations in pharmaceuticals to outsource R&D activities to stay ahead of the competition help grow manufactures operating in the global glycomics market. Increasing collaborate activities of market players and research institutes to study proteomics and glycomics to discover solutions on genetic diseases drives the global glycomics market.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Glycomics Market
Analysts’ Viewpoint
There is a growing need of research and development activities in the field of glycan to study and understand the drug development lifecycle. Rising prevalence of chronic diseases such as cancer and diabetes, etc., technological advancements in pharmaceutical industry, and increasing research activities in the field of biotechnology to study the glycans are factors expected to create lucrative revenue opportunities for the global glycomics market players. However, there are still some challenges that need to be consider about the high costs of tools. Increasing investments on healthcare and presence of highly advanced research laboratories in the region are some of the factors responsible for the flourishing growth in North America.
Glycomics Market: Overview
Glycomics Market: Key Segments
Glycomics Market: Regional Outlook
Companies Mentioned in Report
Glycomics Market Snapshot
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 0.9 Bn |
|
Market Forecast Value in 2031 |
US$ 3.1 Bn |
|
Growth Rate (CAGR) |
11.2% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Additionally, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview. |
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Glycomics Market – Segmentation
| Product Type |
|
| Application |
|
| End-user |
|
| Region |
|
The global glycomics market was worth US$ 0.9 Bn and is projected to reach a value of US$ 3.1 Bn by the end of 2031
Glycomics market is anticipated to grow at a CAGR of 11.2% during the forecast period
North America accounted for a major share of the global glycomics market
Global glycomics market is driven by increase in research activities on glycomics and rise in R&D investments in pharmaceutical and biotechnology companies
Key players in the global glycomics market include Agilent Technologies, Inc., Asparia Glycomics, Bruker Corporation, Canadian Glycomics Network (GLYCONET), Glyco Expression Technologies, Inc., Glycodiag, Merck KGaA, New England Biolabs, RayBiotech, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Vector Laboratories, and Glyde Bio, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Glycomics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Glycomics Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements
6. Global Glycomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Enzymes
6.3.1.1. Glycosidases
6.3.1.2. Glycosyltransferases
6.3.1.3. Neuraminidases
6.3.1.4. Sialyltransferases
6.3.1.5. Others
6.3.2. Instruments
6.3.2.1. Antibody Arrays
6.3.2.2. HPLC
6.3.2.3. Lectin Arrays
6.3.2.4. MALDI-TOF
6.3.2.5. Other Glycomics Instruments
6.3.3. Kits
6.3.3.1. Glycan Labeling Kits
6.3.3.2. Glycan Purification Kits
6.3.3.3. Glycan Release Kits
6.3.3.4. Others
6.3.4. Reagents
6.3.4.1. Glycoproteins
6.3.4.2. Monosaccharides
6.3.4.3. Oligosaccharides
6.3.4.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Glycomics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnostics
7.3.2. Drug Discovery & Development
7.3.3. Oncology
7.3.4. Immunology
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Glycomics Market Analysis and Forecast End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Academic Research Institute
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Contract Research Organizations
8.4. Market Attractiveness Analysis, by End-user
9. Global Glycomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Glycomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Enzymes
10.2.1.1. Glycosidases
10.2.1.2. Glycosyltransferases
10.2.1.3. Neuraminidases
10.2.1.4. Sialyltransferases
10.2.1.5. Others
10.2.2. Instruments
10.2.2.1. Antibody Arrays
10.2.2.2. HPLC
10.2.2.3. Lectin Arrays
10.2.2.4. MALDI-TOF
10.2.2.5. Other Glycomics Instruments
10.2.3. Kits
10.2.3.1. Glycan Labeling Kits
10.2.3.2. Glycan Purification Kits
10.2.3.3. Glycan Release Kits
10.2.3.4. Others
10.2.4. Reagents
10.2.4.1. Glycoproteins
10.2.4.2. Monosaccharides
10.2.4.3. Oligosaccharides
10.2.4.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnostics
10.3.2. Drug Discovery & Development
10.3.3. Oncology
10.3.4. Immunology
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Academic Research Institute
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Glycomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Enzymes
11.2.1.1. Glycosidases
11.2.1.2. Glycosyltransferases
11.2.1.3. Neuraminidases
11.2.1.4. Sialyltransferases
11.2.1.5. Others
11.2.2. Instruments
11.2.2.1. Antibody Arrays
11.2.2.2. HPLC
11.2.2.3. Lectin Arrays
11.2.2.4. MALDI-TOF
11.2.2.5. Other Glycomics Instruments
11.2.3. Kits
11.2.3.1. Glycan Labeling Kits
11.2.3.2. Glycan Purification Kits
11.2.3.3. Glycan Release Kits
11.2.3.4. Others
11.2.4. Reagents
11.2.4.1. Glycoproteins
11.2.4.2. Monosaccharides
11.2.4.3. Oligosaccharides
11.2.4.4. Others
11.3. Market Value Forecast Application, 2017–2031
11.3.1. Diagnostics
11.3.2. Drug Discovery & Development
11.3.3. Oncology
11.3.4. Immunology
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Academic Research Institute
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Glycomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Enzymes
12.2.1.1. Glycosidases
12.2.1.2. Glycosyltransferases
12.2.1.3. Neuraminidases
12.2.1.4. Sialyltransferases
12.2.1.5. Others
12.2.2. Instruments
12.2.2.1. Antibody Arrays
12.2.2.2. HPLC
12.2.2.3. Lectin Arrays
12.2.2.4. MALDI-TOF
12.2.2.5. Other Glycomics Instruments
12.2.3. Kits
12.2.3.1. Glycan Labeling Kits
12.2.3.2. Glycan Purification Kits
12.2.3.3. Glycan Release Kits
12.2.3.4. Others
12.2.4. Reagents
12.2.4.1. Glycoproteins
12.2.4.2. Monosaccharides
12.2.4.3. Oligosaccharides
12.2.4.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnostics
12.3.2. Drug Discovery & Development
12.3.3. Oncology
12.3.4. Immunology
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Academic Research Institute
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Glycomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Enzymes
13.2.1.1. Glycosidases
13.2.1.2. Glycosyltransferases
13.2.1.3. Neuraminidases
13.2.1.4. Sialyltransferases
13.2.1.5. Others
13.2.2. Instruments
13.2.2.1. Antibody Arrays
13.2.2.2. HPLC
13.2.2.3. Lectin Arrays
13.2.2.4. MALDI-TOF
13.2.2.5. Other Glycomics Instruments
13.2.3. Kits
13.2.3.1. Glycan Labeling Kits
13.2.3.2. Glycan Purification Kits
13.2.3.3. Glycan Release Kits
13.2.3.4. Others
13.2.4. Reagents
13.2.4.1. Glycoproteins
13.2.4.2. Monosaccharides
13.2.4.3. Oligosaccharides
13.2.4.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnostics
13.3.2. Drug Discovery & Development
13.3.3. Oncology
13.3.4. Immunology
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Academic Research Institute
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Glycomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Enzymes
14.2.1.1. Glycosidases
14.2.1.2. Glycosyltransferases
14.2.1.3. Neuraminidases
14.2.1.4. Sialyltransferases
14.2.1.5. Others
14.2.2. Instruments
14.2.2.1. Antibody Arrays
14.2.2.2. HPLC
14.2.2.3. Lectin Arrays
14.2.2.4. MALDI-TOF
14.2.2.5. Other Glycomics Instruments
14.2.3. Kits
14.2.3.1. Glycan Labeling Kits
14.2.3.2. Glycan Purification Kits
14.2.3.3. Glycan Release Kits
14.2.3.4. Others
14.2.4. Reagents
14.2.4.1. Glycoproteins
14.2.4.2. Monosaccharides
14.2.4.3. Oligosaccharides
14.2.4.4. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnostics
14.3.2. Drug Discovery & Development
14.3.3. Oncology
14.3.4. Immunology
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Academic Research Institute
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Agilent Technologies, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Asparia Glycomics
15.4.2.1. Company Description
15.4.2.2. SWOT Analysis
15.4.3. Bruker Corporation
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Canadian Glycomics Network (GLYCONET)
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. SWOT Analysis
15.4.5. Glyco Expression Technologies, Inc.
15.4.5.1. Company Description
15.4.5.2. SWOT Analysis
15.4.6. Glycodiag
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Merck KGaA
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. Financial Overview
15.4.7.4. SWOT Analysis
15.4.8. New England Biolabs
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. SWOT Analysis
15.4.9. RayBiotech, Inc.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Shimadzu Corporation
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. Thermo Fisher Scientific, Inc.
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. Vector Laboratories
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. SWOT Analysis
15.4.13. Glyde Bio, Inc.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis
List of Tables
Table 01: Global Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031
Table 03: Global Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 04: Global Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031
Table 05: Global Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031
Table 06: Global Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 07: Global Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 08: Global Glycomics Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 09: North America Glycomics Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: North America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031
Table 12: North America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 13: North America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031
Table 14: North America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031
Table 15: North America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: North America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Europe Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Europe Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031
Table 20: Europe Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 21: Europe Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031
Table 22: Europe Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031
Table 23: Europe Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Europe Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031
Table 28: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 29: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031
Table 30: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031
Table 31: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 32: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 33: Latin America Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 34: Latin America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 35: Latin America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031
Table 36: Latin America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 37: Latin America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031
Table 38: Latin America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031
Table 39: Latin America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 40: Latin America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 41: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 42: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 43: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031
Table 44: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 45: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031
Table 46: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031
Table 47: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 48: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Glycomics Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Glycomics Market Value Share, by Product Type, 2020
Figure 03: Global Glycomics Market Value Share, by Application, 2020
Figure 04: Global Glycomics Market Value Share, by End-user, 2020
Figure 05: Global Glycomics Market Value Share, by Region, 2020
Figure 06: Global Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 07: Global Glycomics Market Attractiveness Analysis, by Product Type , 2021–2031
Figure 08: Global Glycomics Market Revenue (US$ Mn), by Enzymes, 2017–2031
Figure 09: Global Glycomics Market Revenue (US$ Mn), by Instruments, 2017–2031
Figure 10: Global Glycomics Market Revenue (US$ Mn), by Kits, 2017–2031
Figure 11: Global Glycomics Market Revenue (US$ Mn), by Reagents, 2017–2031
Figure 12: Global Glycomics Market Value Share Analysis, by Application, 2020 and 2031
Figure 13: Global Glycomics Market Attractiveness Analysis, by Application, 2021–2031
Figure 14: Global Glycomics Market Revenue (US$ Mn), by Diagnostics, 2017–2031
Figure 15: Global Glycomics Market Revenue (US$ Mn), by Drug Discovery & Development, 2017–2031
Figure 16: Global Glycomics Market Revenue (US$ Mn), by Oncology, 2017–2031
Figure 17: Global Glycomics Market Revenue (US$ Mn), by Immunology, 2017–2031
Figure 18: Global Glycomics Market Value (US$ Mn), by Others, 2017–2031
Figure 19: Global Glycomics Market Value Share Analysis, by End-user, 2020 and 2031
Figure 20: Global Glycomics Market Attractiveness Analysis, by End-user, 2021–2031
Figure 21: Global Glycomics Market Revenue (US$ Mn), by Academic Research Institutes, 2017–2031
Figure 22: Global Glycomics Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 23: Global Glycomics Market Value (US$ Mn), by Contract Research Organizations, 2017–2031
Figure 24: Global Glycomics Market Value Share Analysis, by Region, 2020 and 2031
Figure 25: Global Glycomics Market Analysis, by Region
Figure 26: North America Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 27: North America Glycomics Market Analysis Value Share Analysis, by Country, 2020 and 2031
Figure 28: North America Glycomics Market Analysis Attractiveness Analysis, by Country 2021–2031
Figure 29: North America Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 30: North America Glycomics Market Attractiveness Analysis, by Product Type , 2021–2031
Figure 31: North America Glycomics Market Value Share Analysis, by Application, 2020 and 2031
Figure 32: North America Glycomics Market Attractiveness Analysis, by Application, 2021–2031
Figure 33: North America Glycomics Market Value Share Analysis, by End-user, 2020 and 2031
Figure 34: North America Glycomics Market Attractiveness Analysis, by End-user, 2021–2031
Figure 35: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 36: Europe Glycomics Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 37: Europe Glycomics Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 38: Europe Glycomics Market Value Share Analysis, by Product Type,
Figure 39: Europe Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 40: Europe Glycomics Market Value Share Analysis, by Application, 2020 and 2031
Figure 41: Europe Glycomics Market Attractiveness Analysis, by Application, 2021–2031
Figure 42: Europe Glycomics Market Value Share Analysis, by End-user, 2020 and 2031
Figure 43: Europe Glycomics Market Attractiveness Analysis, by End-user, 2021–2031
Figure 44: Asia Pacific Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 45: Asia Pacific Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 46: Asia Pacific Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 47: Asia Pacific Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 48: Asia Pacific Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 49: Asia Pacific Glycomics Market Value Share Analysis, by Application, 2020 and 2031
Figure 50: Asia Pacific Glycomics Market Attractiveness Analysis, by Application, 2021–2031
Figure 51: Asia Pacific Glycomics Market Value Share Analysis, by End-user, 2020 and 2031
Figure 52: Asia Pacific Glycomics Market Attractiveness Analysis, by End-user, 2021–2031
Figure 53: Latin America Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 54: Latin America Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 55: Latin America Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 56: Latin America Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 57: Latin America Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 58: Latin America Glycomics Market Value Share Analysis, by Application, 2020 and 2031
Figure 59: Latin America Glycomics Market Attractiveness Analysis, by Application, 2021–2031
Figure 60: Latin America Glycomics Market Value Share Analysis, by End-user, 2020 and 2031
Figure 61: Latin America Glycomics Market Attractiveness Analysis, by End-user, 2021–2031
Figure 62: Middle East & Africa Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 63: Middle East & Africa Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 64: Middle East & Africa Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 65: Middle East & Africa Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 66: Middle East & Africa Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 67: Middle East & Africa Glycomics Market Value Share Analysis, by Application, 2020 and 2031
Figure 68: Middle East & Africa Glycomics Market Attractiveness Analysis, by Application, 2021–2031
Figure 69: Middle East & Africa Glycomics Market Value Share Analysis, by End-user, 2020 and 2031
Figure 70: Middle East & Africa Glycomics Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Glycomics Market Insights, 2021-2031
